Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ernst J Schaefer

Showing results (1-10 of 237) with videos related to

Pageof 24
Sort By:
Clinical Chemistry|February 27, 2010
Northern light: a commentary on the 2009 Canadian Guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in adultsErnst J Schaefer
Current Opinion in Lipidology|May 3, 2014
Editorial introductionErnst J Schaefer
The American Journal of Clinical Nutrition|January 30, 2002
Lipoproteins, nutrition, and heart diseaseErnst J Schaefer
Current Opinion in Lipidology|May 9, 2013
Effects of cholesteryl ester transfer protein inhibitors on human lipoprotein metabolism: why have they failed in lowering coronary heart disease risk?Ernst J Schaefer
Clinical Chemistry|September 19, 2009
Limitations of automated remnant lipoprotein cholesterol assay for diagnostic useErnst J Schaefer
Current Opinion in Lipidology|May 9, 2013
Editorial introduction. Human lipoprotein metabolism and therapeutic options for coronary heart disease (CHD) reductionErnst J Schaefer
Atherosclerosis. Supplements|November 14, 2002
Importance of dietary management and practical patient counseling--US perspectiveErnst J Schaefer
Current Atherosclerosis Reports|August 7, 2002
New targets for medical treatment of lipid disordersMargaret E Brousseau, Ernst J Schaefer
Current Opinion in Lipidology|July 13, 2006
Cholesteryl ester transfer protein inhibition, high-density lipoprotein metabolism and heart disease risk reductionErnst J Schaefer, Bela F Asztalos
The American Journal of Cardiology|December 6, 2007
Increasing high-density lipoprotein cholesterol, inhibition of cholesteryl ester transfer protein, and heart disease risk reductionErnst J Schaefer, Bela F Asztalos
Pageof 24

Showing results (1-10 of 237) with videos related to

Sort By:
Pageof 24
Clinical Chemistry|February 27, 2010
Northern light: a commentary on the 2009 Canadian Guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in adultsErnst J Schaefer
Current Opinion in Lipidology|May 3, 2014
Editorial introductionErnst J Schaefer
The American Journal of Clinical Nutrition|January 30, 2002
Lipoproteins, nutrition, and heart diseaseErnst J Schaefer
Current Opinion in Lipidology|May 9, 2013
Effects of cholesteryl ester transfer protein inhibitors on human lipoprotein metabolism: why have they failed in lowering coronary heart disease risk?Ernst J Schaefer
Clinical Chemistry|September 19, 2009
Limitations of automated remnant lipoprotein cholesterol assay for diagnostic useErnst J Schaefer
Current Opinion in Lipidology|May 9, 2013
Editorial introduction. Human lipoprotein metabolism and therapeutic options for coronary heart disease (CHD) reductionErnst J Schaefer
Atherosclerosis. Supplements|November 14, 2002
Importance of dietary management and practical patient counseling--US perspectiveErnst J Schaefer
Current Atherosclerosis Reports|August 7, 2002
New targets for medical treatment of lipid disordersMargaret E Brousseau, Ernst J Schaefer
Current Opinion in Lipidology|July 13, 2006
Cholesteryl ester transfer protein inhibition, high-density lipoprotein metabolism and heart disease risk reductionErnst J Schaefer, Bela F Asztalos
The American Journal of Cardiology|December 6, 2007
Increasing high-density lipoprotein cholesterol, inhibition of cholesteryl ester transfer protein, and heart disease risk reductionErnst J Schaefer, Bela F Asztalos
Pageof 24